儿童,青少年和年轻人瘤学的"技术性":通过人工智能和沉浸式技术解决不平等问题
Vidya Puthenpura1, Mary Hunter2, Asher M Marks1
1Section of Pediatric Hematology and Oncology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Pediatric blood & cancer
|August 29, 2025
概括
人工智能 (AI) 和虚拟现实 (VR) 等沉浸式技术可以减少儿童和青少年瘤的健康差异. 这些工具提高了年轻癌症患者的护理准入和质量,
科学领域:
- 癌症学
- 卫生信息学
- 数字健康
背景情况:
- 由于社会经济地位,地理位置,种族和种族因素,儿童,青少年和年轻成年人 (AYA) 癌症的健康差异仍然存在.
- 这些因素导致弱势患者获得不平等的护理和更差的健康结果.
研究的目的:
- 探索人工智能 (AI) 和沉浸式技术 (虚拟现实/增强现实 - VR/AR) 的潜力,以解决儿科和AYA瘤方面的健康不平等问题.
- 研究这些技术如何改善年轻癌症患者的生活质量和弥补护理差距.
主要方法:
- 审查新兴技术,特别是人工智能和虚拟现实/增强现实,以及它们在癌症治疗中的应用.
- 分析这些技术如何克服包括数字差距在内的传统护理障碍.
- 探索公平实施的战略,考虑道德和成本方面的挑战.
主要成果:
- 人工智能显示出提高诊断准确度,个性化治疗计划和帮助患者导航的潜力.
- 沉浸式技术 (VR/AR) 提供公平的支持性护理,包括心理支持,疼痛管理,康复和教育.
- 更多的互联网接入为服务不足的人群提供了机会.
结论:
- 整合人工智能和沉浸式技术可以为儿童和AYA患者创造更具包容性和有效的癌症护理环境.
- 公平的实施策略至关重要, 确保这些创新有利于所有患者, 无论他们的背景如何.
- 解决数字沟,伦理问题和成本障碍对于广泛采用至关重要.
相关概念视频
01:29Issues And Trends In Healthcare Delivery System
5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K